Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Constellation Brands
STZ
|
+$1.47B |
| 2 |
TC Energy
TRP
|
+$1.44B |
| 3 |
Broadcom
AVGO
|
+$1.37B |
| 4 |
Alcon
ALC
|
+$1.22B |
| 5 |
UnitedHealth
UNH
|
+$1.02B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$2.86B |
| 2 |
Verizon
VZ
|
+$1.9B |
| 3 |
Booking.com
BKNG
|
+$1.47B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.44B |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$1.31B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.37% |
| 2 | Technology | 16.98% |
| 3 | Consumer Discretionary | 12.52% |
| 4 | Communication Services | 11.95% |
| 5 | Industrials | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRCM
376
DELISTED
CARE.COM, INC.
CRCM
| $12.2M | ﹤0.01% |
1,113,650
-2,343,450
| -68% | -$35.5M |
|
377
ASML
ASML
$695B
| $8.18M | ﹤0.01% |
39,332
+39,324
| +491,550% | +$7.82M |
|
378
Walt Disney
DIS
$178B
| $7.19M | ﹤0.01% |
51,466
+22
| +0% | +$2.92K |
|
379
Viavi Solutions
VIAV
$10.6B
| $5.32M | ﹤0.01% |
400,417
-4,571,839
| -92% | -$59.1M |
|
380
Tenable Holdings
TENB
$4.08B
| $3.23M | ﹤0.01% |
113,000
-225,800
| -67% | -$6.68M |
|
|
TLND
381
DELISTED
Talend S.A. American Depositary Shares
TLND
| $3.15M | ﹤0.01% |
81,500
| – | – |
|
382
Hilton Grand Vacations
HGV
$3.49B
| $2.92M | ﹤0.01% |
91,700
-3,748,564
| -98% | -$112M |
|
383
Banco Bilbao Vizcaya Argentaria
BBVA
$157B
| $1.88M | ﹤0.01% |
337,643
| – | – |
|
|
LGF.A
384
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $1.77M | ﹤0.01% |
144,436
-1,110,855
| -88% | -$16M |
|
385
Ingevity
NGVT
$2.62B
| $1.77M | ﹤0.01% |
+16,808
| New | +$1.69M |
|
|
NVCN
386
DELISTED
Neovasc Inc.
NVCN
| $1.19M | ﹤0.01% |
9,884
| – | – |
|
|
CMLS
387
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $625K | ﹤0.01% |
33,691
+18,482
| +122% | +$323K |
|
388
Ares Management
ARES
$32.1B
| $440K | ﹤0.01% |
+16,800
| New | +$427K |
|
389
Wabtec
WAB
$49.9B
| $72K | ﹤0.01% |
999
-34,911
| -97% | -$2.48M |
|
390
Sony
SONY
$138B
| $31K | ﹤0.01% |
2,950
+2,000
| +211% | +$19.6K |
|
391
KB Financial Group
KB
$41.4B
| $15K | ﹤0.01% |
375
+358
| +2,106% | +$14K |
|
392
Rio Tinto
RIO
$165B
| $15K | ﹤0.01% |
249
+240
| +2,667% | +$14.4K |
|
393
ArcelorMittal
MT
$55.9B
| $12K | ﹤0.01% |
644
+635
| +7,056% | +$12K |
|
|
BBL
394
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $8K | ﹤0.01% |
+152
| New | +$7.26K |
|
395
Barclays
BCS
$94.4B
| $6K | ﹤0.01% |
853
+815
| +2,145% | +$6.44K |
|
396
Fresenius Medical Care
FMS
$12.6B
| $6K | ﹤0.01% |
155
+148
| +2,114% | +$5.86K |
|
397
Prudential
PUK
$34.2B
| $5K | ﹤0.01% |
111
+106
| +2,120% | +$4.41K |
|
|
ACH
398
DELISTED
Alum Corp of China Ltd
ACH
| $5K | ﹤0.01% |
523
+499
| +2,079% | +$4.7K |
|
399
Petrobras
PBR
$114B
| $3K | ﹤0.01% |
165
-32
| -16% | -$488 |
|
400
Banco Santander
SAN
$211B
| $1K | ﹤0.01% |
206
+197
| +2,189% | +$885 |
|
Similar funds
Capital Research Global Investors's Q2 2019 Portfolio in Review
As of Q2 2019, Capital Research Global Investors held 443 positions worth $315B, down 0.14% from $315B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Capital Research Global Investors's Q2 2019 filing shows 29 new, 207 increased, 136 reduced and 42 closed positions. Its largest new stake was TC Energy: 30,064,463 shares worth $1.49B. The largest sale was AbbVie, an estimated $2.86B.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
- Capital Research Global Investors's largest Q2 2019 buy was TC Energy: 30,064,463 shares worth $1.49B.
- Capital Research Global Investors added most to Constellation Brands in Q2 2019, an estimated $1.47B increase.
- Capital Research Global Investors's biggest Q2 2019 reduction was AbbVie, cutting an estimated $2.86B.
- Capital Research Global Investors fully exited Johnson Controls International in Q2 2019, selling an estimated $403M.
- Capital Research Global Investors's ten largest holdings make up 28% of its $315B portfolio in Q2 2019.
- Capital Research Global Investors opened 29 new positions and closed 42 in Q2 2019.
- Capital Research Global Investors's portfolio value fell 0.14% quarter-over-quarter to $315B.
Based on Capital Research Global Investors's 13F filing for Q2 2019, filed 14 Aug 2019.